Tekmira Pharmaceuticals Corporation Conference Call and Webcast Advisory: Corporate Update and Second Quarter 2012 Results

Published: Aug 10, 2012

VANCOUVER, British Columbia, Aug. 9, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold a conference call and webcast on Tuesday, August 14, 2012 at 1:30 pm Pacific Time (4:30 pm Eastern Time) to provide a corporate update and report financial and operating results for the second quarter ended June 30, 2012.

Back to news